{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:49:33Z","timestamp":1787237373334,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06847-y","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:55:04Z","timestamp":1752569704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integration of scRNA-seq and ST-seq identifies hyperproliferative RRM2+ cells features and therapeutic targets in gastric cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Shuai","family":"Ping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"7","key":"6847_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346. https:\/\/doi.org\/10.1002\/ijc.35278","journal-title":"Int J Cancer"},{"issue":"8","key":"6847_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.20892\/j.issn.2095-3941.2024.0159","volume":"21","author":"N Tan","year":"2024","unstructured":"Tan N, Wu H, Cao M, Yang F, Yan X, He S, Cao M, Zhang S, Teng Y, Li Q, et al. Global, regional, and national burden of early-onset gastric cancer. Cancer Biol Med. 2024;21(8):667\u201378. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0159","journal-title":"Cancer Biol Med"},{"issue":"11","key":"6847_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust T\u00c5, Tervonen H, Thursfield V, Ransom D, Shack L, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493\u2013505. https:\/\/doi.org\/10.1016\/S1470-2045(19)30456-5","journal-title":"Lancet Oncol"},{"issue":"9","key":"6847_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4251\/wjgo.v2.i9.342","volume":"2","author":"L Fuccio","year":"2010","unstructured":"Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol. 2010;2(9):342\u20137. https:\/\/doi.org\/10.4251\/wjgo.v2.i9.342","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"6847_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41591-024-03450-4","volume":"31","author":"L Shen","year":"2025","unstructured":"Shen L, Zhang Y, Li Z, Zhang X, Gao X, Liu B, Wang Y, Ba Y, Li N, Zhang R, et al. First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial. Nat Med. 2025;31(4):1163\u201370. https:\/\/doi.org\/10.1038\/s41591-024-03450-4","journal-title":"Nat Med"},{"issue":"10494","key":"6847_CR6","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0140-6736(25)00860-8","volume":"405","author":"C Qi","year":"2025","unstructured":"Qi C, Liu C, Peng Z, Zhang Y, Wei J, Qiu W, Zhang X, Pan H, Niu Z, Qiu M, et al. Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician\u2019s choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial. Lancet. 2025;405(10494):2049\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(25)00860-8","journal-title":"Lancet"},{"issue":"1","key":"6847_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"W-L Guan","year":"2023","unstructured":"Guan W-L, He Y, Xu R-H. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3","journal-title":"J Hematol Oncol"},{"issue":"5","key":"6847_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"2","key":"6847_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, et al. Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"issue":"11","key":"6847_CR10","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s11010-023-04886-x","volume":"479","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Wu S, Xiao J, Zhang Z. Ferroptosis: opening up potential targets for gastric cancer treatment. Mol Cell Biochem. 2024;479(11):2863\u201374. https:\/\/doi.org\/10.1007\/s11010-023-04886-x","journal-title":"Mol Cell Biochem"},{"issue":"11\u201312","key":"6847_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s10495-020-01638-w","volume":"25","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wei Z, Pan K, Li J, Chen Q. The function and mechanism of ferroptosis in cancer. Apoptosis. 2020;25(11\u201312):786\u201398. https:\/\/doi.org\/10.1007\/s10495-020-01638-w","journal-title":"Apoptosis"},{"issue":"2","key":"6847_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Res"},{"issue":"5","key":"6847_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nat Rev Clin Oncol"},{"key":"6847_CR14","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D. Iron metabolism in ferroptosis. Front Cell Dev Biol. 2020;8:590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"6847_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H-L, Huang Z-J, Lin Z-T, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"issue":"3","key":"6847_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014","journal-title":"Trends Cell Biol"},{"issue":"6","key":"6847_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002","journal-title":"Cancer Cell"},{"issue":"1","key":"6847_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","volume":"8","author":"Y Du","year":"2022","unstructured":"Du Y, Guo Z. Recent progress in ferroptosis: inducers and inhibitors. Cell Death Discov. 2022;8(1):501. https:\/\/doi.org\/10.1038\/s41420-022-01297-7","journal-title":"Cell Death Discov"},{"issue":"9","key":"6847_CR19","doi-asserted-by":"publisher","first-page":"114697","DOI":"10.1016\/j.celrep.2024.114697","volume":"43","author":"Z Luo","year":"2024","unstructured":"Luo Z, Mei J, Wang X, Wang R, He Z, Geffen Y, Sun X, Zhang X, Xu J, Wan R, et al. Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell Rep. 2024;43(9):114697. https:\/\/doi.org\/10.1016\/j.celrep.2024.114697","journal-title":"Cell Rep"},{"issue":"3","key":"6847_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15212\/bioi-2022-0010","volume":"4","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zeng Y, Xiao X, Liu H, Zhou B, Luo B, Saw PE, Jiang Q. Targeted imaging of tumor associated macrophages in breast cancer. BIO Integr. 2023;4(3):114\u201324. https:\/\/doi.org\/10.15212\/bioi-2022-0010","journal-title":"BIO Integr"},{"issue":"1","key":"6847_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0013","volume":"5","author":"H Xu","year":"2024","unstructured":"Xu H, Guo Z, Li M, Chaves HV, Pinto VdPT, Filho GC, Du M, Bezerra MM. Copper-based nanomaterials for image-guided cancer therapy. BIO Integr. 2024;5(1):1\u201314. https:\/\/doi.org\/10.15212\/bioi-2024-0013","journal-title":"BIO Integr"},{"key":"6847_CR22","doi-asserted-by":"publisher","unstructured":"Chen Y, Sun Y, Xu Y, Lin W-W, Luo Z, Han Z, Liu S, Qi B, Sun C, Go K et al. Single-cell integration analysis of heterotopic ossification and fibrocartilage developmental lineage: endoplasmic reticulum stress effector Xbp1 transcriptionally regulates the notch signaling pathway to mediate fibrocartilage differentiation. Oxid Med Cell Longev. 2021;2021:7663366. https:\/\/doi.org\/10.1155\/2021\/7663366","DOI":"10.1155\/2021\/7663366"},{"key":"6847_CR23","doi-asserted-by":"publisher","unstructured":"Zhang P, Yang M, Zhang Y, Xiao S, Lai X, Tan A, Du S, Li S. Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2019;27(6). https:\/\/doi.org\/10.1016\/j.celrep.2019.04.052","DOI":"10.1016\/j.celrep.2019.04.052"},{"issue":"11","key":"6847_CR24","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","volume":"26","author":"A Sathe","year":"2020","unstructured":"Sathe A, Grimes SM, Lau BT, Chen J, Suarez C, Huang RJ, Poultsides G, Ji HP. Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin Cancer Res. 2020;26(11):2640\u201353. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3231","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6847_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X, Wu J, Liu B, Ying X, Liu Y. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut. 2021;70(3):464\u201375. https:\/\/doi.org\/10.1136\/gutjnl-2019-320368","journal-title":"Gut"},{"issue":"3","key":"6847_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK, Tay ST, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12(3):670\u201391. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0683","journal-title":"Cancer Discov"},{"issue":"3","key":"6847_CR27","doi-asserted-by":"publisher","first-page":"e13376","DOI":"10.1111\/cpr.13376","volume":"56","author":"Z Wang","year":"2023","unstructured":"Wang Z, Dai Z, Zhang H, Zhang N, Liang X, Peng L, Zhang J, Liu Z, Peng Y, Cheng Q, et al. Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy. Cell Prolif. 2023;56(3):e13376. https:\/\/doi.org\/10.1111\/cpr.13376","journal-title":"Cell Prolif"},{"issue":"6","key":"6847_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-022-01448-2","volume":"41","author":"L Tian","year":"2023","unstructured":"Tian L, Chen F, Macosko EZ. The expanding vistas of spatial transcriptomics. Nat Biotechnol. 2023;41(6):773\u201382. https:\/\/doi.org\/10.1038\/s41587-022-01448-2","journal-title":"Nat Biotechnol"},{"issue":"11","key":"6847_CR29","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","volume":"56","author":"AM Khaliq","year":"2024","unstructured":"Khaliq AM, Rajamohan M, Saeed O, Mansouri K, Adil A, Zhang C, Turk A, Carstens JL, House M, Hayat S, et al. Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity. Nat Genet. 2024;56(11):2455\u201365. https:\/\/doi.org\/10.1038\/s41588-024-01914-4","journal-title":"Nat Genet"},{"issue":"1","key":"6847_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13046-022-02385-3","volume":"41","author":"B Zheng","year":"2022","unstructured":"Zheng B, Fang L. Spatially resolved transcriptomics provide a new method for cancer research. J Exp Clin Cancer Res. 2022;41(1):179. https:\/\/doi.org\/10.1186\/s13046-022-02385-3","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"6847_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P-R, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0","journal-title":"Nat Methods"},{"issue":"10","key":"6847_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382. https:\/\/doi.org\/10.1038\/nmeth.4402","journal-title":"Nat Methods"},{"issue":"4","key":"6847_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136. https:\/\/doi.org\/10.1038\/nbt.2859","journal-title":"Nat Biotechnol"},{"key":"6847_CR34","doi-asserted-by":"crossref","unstructured":"William C, Wangmo C, Ranjan A. Unravelling the application of machine learning in cancer biomarker discovery. 2023;2.","DOI":"10.58567\/ci02010001"},{"key":"6847_CR35","doi-asserted-by":"publisher","unstructured":"Yang L, He Y-T, Dong S, Wei X-W, Chen Z-H, Zhang B, Chen W-D, Yang X-R, Wang F, Shang X-M, et al. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. J Immunother Cancer. 2022;10(2). https:\/\/doi.org\/10.1136\/jitc-2021-003534","DOI":"10.1136\/jitc-2021-003534"},{"issue":"9","key":"6847_CR36","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41587-022-01273-7","volume":"40","author":"Y Ma","year":"2022","unstructured":"Ma Y, Zhou X. Spatially informed cell-type deconvolution for spatial transcriptomics. Nat Biotechnol. 2022;40(9):1349\u201359. https:\/\/doi.org\/10.1038\/s41587-022-01273-7","journal-title":"Nat Biotechnol"},{"key":"6847_CR37","doi-asserted-by":"publisher","unstructured":"Han D, Han Y, Guo W, Wei W, Yang S, Xiang J, Che J, Zhu L, Hang J, van den Ende T, et al. High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy. J Immunother Cancer. 2023;11(11). https:\/\/doi.org\/10.1136\/jitc-2023-007847","DOI":"10.1136\/jitc-2023-007847"},{"key":"6847_CR38","doi-asserted-by":"publisher","first-page":"1010785","DOI":"10.3389\/fphar.2022.1010785","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Luo Z, Sun Y, Li F, Han Z, Qi B, Lin J, Lin W-W, Yao M, Kang X, et al. Exercise improves choroid plexus epithelial cells metabolism to prevent glial cell-associated neurodegeneration. Front Pharmacol. 2022;13:1010785. https:\/\/doi.org\/10.3389\/fphar.2022.1010785","journal-title":"Front Pharmacol"},{"issue":"2","key":"6847_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.gastro.2021.10.036","volume":"162","author":"JR Goldenring","year":"2022","unstructured":"Goldenring JR, Mills JC. Cellular plasticity, reprogramming, and regeneration: metaplasia in the stomach and beyond. Gastroenterology. 2022;162(2):415\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2021.10.036","journal-title":"Gastroenterology"},{"key":"6847_CR40","doi-asserted-by":"publisher","unstructured":"Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, Geng D, Yue J, Tang Y, Tian L, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024;134(10). https:\/\/doi.org\/10.1172\/JCI174587","DOI":"10.1172\/JCI174587"},{"issue":"22","key":"6847_CR41","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.7150\/jca.30074","volume":"10","author":"D-D Xiong","year":"2019","unstructured":"Xiong D-D, Zeng C-M, Jiang L, Luo D-Z, Chen G. Ki-67\/MKI67 as a predictive biomarker for clinical outcome in gastric cancer patients: an updated meta-analysis and systematic review involving 53 studies and 7078 patients. J Cancer. 2019;10(22):5339\u201354. https:\/\/doi.org\/10.7150\/jca.30074","journal-title":"J Cancer"},{"issue":"4","key":"6847_CR42","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.4143\/crt.2018.663","volume":"51","author":"S-I Go","year":"2019","unstructured":"Go S-I, Ko GH, Lee WS, Lee J-H, Jeong S-H, Lee Y-J, Hong SC, Ha WS. The use of CD44 variant 9 and Ki-67 combination can predicts prognosis better than their single use in early gastric cancer. Cancer Res Treat. 2019;51(4):1411\u20139. https:\/\/doi.org\/10.4143\/crt.2018.663","journal-title":"Cancer Res Treat"},{"issue":"2","key":"6847_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1158\/0008-5472.CAN-24-1509","volume":"85","author":"X Wang","year":"2025","unstructured":"Wang X, Wang H, Lu Z, Liu X, Chai W, Wang W, Feng J, Yang S, Yang W, Cheng H, et al. Spatial and single-cell analyses reveal heterogeneity of DNAM-1 receptor-ligand interactions that instructs intratumoral \u03b3\u03b4T-cell activity. Cancer Res. 2025;85(2):277\u201398. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-1509","journal-title":"Cancer Res"},{"issue":"4","key":"6847_CR44","doi-asserted-by":"publisher","first-page":"102043","DOI":"10.1016\/j.xcrm.2025.102043","volume":"6","author":"T Liao","year":"2025","unstructured":"Liao T, Zeng Y, Xu W, Shi X, Shen C, Du Y, Zhang M, Zhang Y, Li L, Ding P, et al. A spatially resolved transcriptome landscape during thyroid cancer progression. Cell Rep Med. 2025;6(4):102043. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102043","journal-title":"Cell Rep Med"},{"issue":"1","key":"6847_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41420-022-00989-4","volume":"8","author":"R Wang","year":"2022","unstructured":"Wang R, Xie S, Zhu S, Sun Y, Shi B, Li D, Kang T, Wang Y, Xu Z, Liu H. Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia. Cell Death Discov. 2022;8(1):180. https:\/\/doi.org\/10.1038\/s41420-022-00989-4","journal-title":"Cell Death Discov"},{"issue":"8","key":"6847_CR46","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.1021\/acsomega.0c06191","volume":"6","author":"L Ivanova","year":"2021","unstructured":"Ivanova L, Rausalu K, \u017dusinaite E, Tammiku-Taul J, Merits A, Karelson M. 1,3-Thiazolbenzamide derivatives as Chikungunya virus nsP2 protease inhibitors. ACS Omega. 2021;6(8):5786\u201394. https:\/\/doi.org\/10.1021\/acsomega.0c06191","journal-title":"ACS Omega"},{"issue":"6294","key":"6847_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aaf2403","volume":"353","author":"PL St\u00e5hl","year":"2016","unstructured":"St\u00e5hl PL, Salm\u00e9n F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, Giacomello S, Asp M, Westholm JO, Huss M, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353(6294):78\u201382. https:\/\/doi.org\/10.1126\/science.aaf2403","journal-title":"Science"},{"issue":"6","key":"6847_CR48","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41592-022-01480-9","volume":"19","author":"B Li","year":"2022","unstructured":"Li B, Zhang W, Guo C, Xu H, Li L, Fang M, Hu Y, Zhang X, Yao X, Tang M, et al. Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution. Nat Methods. 2022;19(6):662\u201370. https:\/\/doi.org\/10.1038\/s41592-022-01480-9","journal-title":"Nat Methods"},{"issue":"1","key":"6847_CR49","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41467-023-37168-7","volume":"14","author":"H Li","year":"2023","unstructured":"Li H, Zhou J, Li Z, Chen S, Liao X, Zhang B, Zhang R, Wang Y, Sun S, Gao X. A comprehensive benchmarking with practical guidelines for cellular deconvolution of spatial transcriptomics. Nat Commun. 2023;14(1):1548. https:\/\/doi.org\/10.1038\/s41467-023-37168-7","journal-title":"Nat Commun"},{"issue":"1","key":"6847_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0012","volume":"5","author":"Z Guo","year":"2024","unstructured":"Guo Z, Saw PE, Jon S. Non-invasive physical stimulation to modulate the tumor microenvironment: unveiling a new frontier in cancer therapy. BIO Integr. 2024;5(1):1\u201314. https:\/\/doi.org\/10.15212\/bioi-2024-0012","journal-title":"BIO Integr"},{"key":"6847_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-biochem-013118-111843","volume":"89","author":"BL Greene","year":"2020","unstructured":"Greene BL, Kang G, Cui C, Bennati M, Nocera DG, Drennan CL, Stubbe J. Ribonucleotide reductases: structure, chemistry, and metabolism suggest new therapeutic targets. Annu Rev Biochem. 2020;89:45\u201375. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111843","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"6847_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00239-002-2311-7","volume":"55","author":"E Torrents","year":"2002","unstructured":"Torrents E, Aloy P, Gibert I, Rodr\u00edguez-Trelles F. Ribonucleotide reductases: divergent evolution of an ancient enzyme. J Mol Evol. 2002;55(2):138\u201352.","journal-title":"J Mol Evol"},{"issue":"23","key":"6847_CR53","doi-asserted-by":"publisher","first-page":"17747","DOI":"10.1074\/jbc.M000799200","volume":"275","author":"A Chabes","year":"2000","unstructured":"Chabes A, Thelander L. Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks. J Biol Chem. 2000;275(23):17747\u201353.","journal-title":"J Biol Chem"},{"issue":"3","key":"6847_CR54","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.18632\/aging.202292","volume":"13","author":"C-Y Jin","year":"2020","unstructured":"Jin C-Y, Du L, Nuerlan AH, Wang X-L, Yang Y-W, Guo R. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma. Aging. 2020;13(3):3518\u201335. https:\/\/doi.org\/10.18632\/aging.202292","journal-title":"Aging"},{"issue":"13","key":"6847_CR55","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1158\/1078-0432.CCR-13-0073","volume":"19","author":"MA Rahman","year":"2013","unstructured":"Rahman MA, Amin ARMR, Wang D, Koenig L, Nannapaneni S, Chen Z, Wang Z, Sica G, Deng X, Chen ZG, et al. RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy. Clin Cancer Res. 2013;19(13):3416\u201328. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0073","journal-title":"Clin Cancer Res"},{"issue":"9","key":"6847_CR56","doi-asserted-by":"publisher","first-page":"e3047","DOI":"10.1038\/cddis.2017.402","volume":"8","author":"P Han","year":"2017","unstructured":"Han P, Chen R-H, Wang F, Zeng J-Y, Yu S-T, Xu L-H, Cai Q, Liang F-Y, Xia T-L, Lin Z-R, et al. Novel chimeric transcript RRM2-c2orf48 promotes metastasis in nasopharyngeal carcinoma. Cell Death Dis. 2017;8(9):e3047. https:\/\/doi.org\/10.1038\/cddis.2017.402","journal-title":"Cell Death Dis"},{"issue":"10","key":"6847_CR57","first-page":"2245","volume":"58","author":"ML Kuo","year":"1998","unstructured":"Kuo ML, Kinsella TJ. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Cancer Res. 1998;58(10):2245\u201352.","journal-title":"Cancer Res"},{"issue":"9","key":"6847_CR58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12032-022-01715-x","volume":"39","author":"Q Liu","year":"2022","unstructured":"Liu Q, Song C, Li J, Liu M, Fu L, Jiang J, Zeng Z, Zhu H. E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2. Med Oncol. 2022;39(9):124. https:\/\/doi.org\/10.1007\/s12032-022-01715-x","journal-title":"Med Oncol"},{"issue":"20","key":"6847_CR59","doi-asserted-by":"publisher","first-page":"eade7236","DOI":"10.1126\/sciadv.ade7236","volume":"9","author":"EN Perrault","year":"2023","unstructured":"Perrault EN, Shireman JM, Ali ES, Lin P, Preddy I, Park C, Budhiraja S, Baisiwala S, Dixit K, James CD, et al. Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. Sci Adv. 2023;9(20):eade7236. https:\/\/doi.org\/10.1126\/sciadv.ade7236","journal-title":"Sci Adv"},{"issue":"16","key":"6847_CR60","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.2174\/1871520621999210104201553","volume":"21","author":"DG R\u00fcstem","year":"2021","unstructured":"R\u00fcstem DG, Atay S, Aydin HH, Ak H. Synergistic interactions between GW8510 and gemcitabine in an in vitro model of pancreatic cancer. Anticancer Agents Med Chem. 2021;21(16):2204\u201315. https:\/\/doi.org\/10.2174\/1871520621999210104201553","journal-title":"Anticancer Agents Med Chem"},{"issue":"13","key":"6847_CR61","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1038\/s41388-018-0584-6","volume":"38","author":"C-W Chen","year":"2019","unstructured":"Chen C-W, Li Y, Hu S, Zhou W, Meng Y, Li Z, Zhang Y, Sun J, Bo Z, DePamphilis ML, et al. DHS (trans-4,4\u2019-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2). Oncogene. 2019;38(13):2364\u201379. https:\/\/doi.org\/10.1038\/s41388-018-0584-6","journal-title":"Oncogene"},{"issue":"13","key":"6847_CR62","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1042\/CS20180010","volume":"132","author":"P Chen","year":"2018","unstructured":"Chen P, Wu J-N, Shu Y, Jiang H-G, Zhao X-H, Qian H, Chen K, Lan T, Chen C-G, Li J. Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction. Clin Sci (Lond). 2018;132(13):1417\u201333. https:\/\/doi.org\/10.1042\/CS20180010","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"6847_CR63","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s42003-021-02844-1","volume":"4","author":"B Das","year":"2021","unstructured":"Das B, Jain N, Mallick B. piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair. Commun Biol. 2021;4(1):1312. https:\/\/doi.org\/10.1038\/s42003-021-02844-1","journal-title":"Commun Biol"},{"issue":"18","key":"6847_CR64","doi-asserted-by":"publisher","first-page":"e2100881","DOI":"10.1002\/advs.202100881","volume":"8","author":"W Xiong","year":"2021","unstructured":"Xiong W, Zhang B, Yu H, Zhu L, Yi L, Jin X. RRM2 regulates sensitivity to sunitinib and PD-1 blockade in renal cancer by stabilizing ANXA1 and activating the AKT pathway. Adv Sci (Weinh). 2021;8(18):e2100881. https:\/\/doi.org\/10.1002\/advs.202100881","journal-title":"Adv Sci (Weinh)"},{"issue":"7664","key":"6847_CR65","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137. https:\/\/doi.org\/10.1038\/nature23007","journal-title":"Nature"},{"issue":"7","key":"6847_CR66","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314. https:\/\/doi.org\/10.1038\/s41568-019-0149-1","journal-title":"Nat Rev Cancer"},{"key":"6847_CR67","doi-asserted-by":"publisher","first-page":"110710","DOI":"10.1016\/j.biopha.2020.110710","volume":"130","author":"B Li","year":"2020","unstructured":"Li B, Yang L, Peng X, Fan Q, Wei S, Yang S, Li X, Jin H, Wu B, Huang M, et al. Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers. Biomed Pharmacother. 2020;130:110710. https:\/\/doi.org\/10.1016\/j.biopha.2020.110710","journal-title":"Biomed Pharmacother"},{"key":"6847_CR68","doi-asserted-by":"publisher","unstructured":"Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X, et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell. 2018;33(5). https:\/\/doi.org\/10.1016\/j.ccell.2018.03.017","DOI":"10.1016\/j.ccell.2018.03.017"},{"issue":"1","key":"6847_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5847\/wjem.j.1920-8642.2022.015","volume":"13","author":"X-F Guo","year":"2022","unstructured":"Guo X-F, Gu S-S, Wang J, Sun H, Zhang Y-J, Yu P-F, Zhang J-S, Jiang L. Protective effect of mesenchymal stem cell-derived exosomal treatment of hippocampal neurons against oxygen-glucose deprivation\/reperfusion-induced injury. World J Emerg Med. 2022;13(1):46\u201353. https:\/\/doi.org\/10.5847\/wjem.j.1920-8642.2022.015","journal-title":"World J Emerg Med"},{"issue":"1","key":"6847_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0066","volume":"5","author":"A Mokashi","year":"2024","unstructured":"Mokashi A, Bhatia NM. Integrated network ethnopharmacology, molecular docking, and ADMET analysis strategy for exploring the anti-breast cancer activity of ayurvedic botanicals targeting the progesterone receptor. BIO Integr. 2024;5(1):1\u201317. https:\/\/doi.org\/10.15212\/bioi-2024-0066","journal-title":"BIO Integr"},{"issue":"1","key":"6847_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s42114-025-01213-4","volume":"8","author":"YW He","year":"2025","unstructured":"He YW, Luo ZW, Nie XS, Du YM, Sun R, Sun JM, Lin ZH, Wan RW, Chen WB, Feng XT, et al. An injectable multi-functional composite bioactive hydrogel for bone regeneration via immunoregulatory and osteogenesis effects. Adv Compos Hybrid Mater. 2025;8(1):23. https:\/\/doi.org\/10.1007\/s42114-025-01213-4","journal-title":"Adv Compos Hybrid Mater"},{"issue":"7860","key":"6847_CR72","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390. https:\/\/doi.org\/10.1038\/s41586-021-03539-7","journal-title":"Nature"},{"key":"6847_CR73","doi-asserted-by":"publisher","unstructured":"Liu J, Zhang C, Wang J, Hu W, Feng Z. The regulation of ferroptosis by tumor suppressor p53 and its pathway. Int J Mol Sci. 2020;21(21). https:\/\/doi.org\/10.3390\/ijms21218387","DOI":"10.3390\/ijms21218387"},{"key":"6847_CR74","doi-asserted-by":"publisher","first-page":"0080","DOI":"10.34133\/research.0080","volume":"6","author":"X Ji","year":"2023","unstructured":"Ji X, Tian X, Feng S, Zhang L, Wang J, Guo R, Zhu Y, Yu X, Zhang Y, Du H, et al. Intermittent F-actin perturbations by magnetic fields inhibit breast cancer metastasis. Res (Wash D C). 2023;6:0080. https:\/\/doi.org\/10.34133\/research.0080","journal-title":"Res (Wash D C)"},{"issue":"7545","key":"6847_CR75","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang S-J, Su T, Hibshoosh H, Baer R, Gu W. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362. https:\/\/doi.org\/10.1038\/nature14344","journal-title":"Nature"},{"issue":"7","key":"6847_CR76","doi-asserted-by":"publisher","first-page":"e47563","DOI":"10.15252\/embr.201847563","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Zhang X, Cui W, Liu Y, Sun Q-R, He Q, Zhao S, Zhang G-A, Wang Y, et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 2019;20(7):e47563. https:\/\/doi.org\/10.15252\/embr.201847563","journal-title":"EMBO Rep"},{"issue":"44","key":"6847_CR77","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang S-J, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A. 2016;113(44):E6806\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6847_CR78","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bioactmat.2025.02.041","volume":"49","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhao X, Zhang W, Wei X, Chen X-L, Wang X. Zn-DHM nanozymes regulate metabolic and immune homeostasis for early diabetic wound therapy. Bioact Mater. 2025;49:63\u201384. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.02.041","journal-title":"Bioact Mater"},{"issue":"1","key":"6847_CR79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1","journal-title":"Signal Transduct Target Ther"},{"key":"6847_CR80","doi-asserted-by":"publisher","first-page":"110471","DOI":"10.1016\/j.cbi.2023.110471","volume":"378","author":"L Luo","year":"2023","unstructured":"Luo L, Chen X, Huang F. Machine learning revealed ferroptosis features and ferroptosis-related gene-based immune microenvironment in lung adenocarcinoma. Chem Biol Interact. 2023;378:110471. https:\/\/doi.org\/10.1016\/j.cbi.2023.110471","journal-title":"Chem Biol Interact"},{"issue":"1","key":"6847_CR81","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12935-022-02699-4","volume":"22","author":"B Deng","year":"2022","unstructured":"Deng B, Xiang J, Liang Z, Luo L. Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma. Cancer Cell Int. 2022;22(1):292. https:\/\/doi.org\/10.1186\/s12935-022-02699-4","journal-title":"Cancer Cell Int"},{"issue":"1","key":"6847_CR82","doi-asserted-by":"publisher","first-page":"e31501","DOI":"10.1002\/jcp.31501","volume":"240","author":"L Guo","year":"2025","unstructured":"Guo L, Zhao Y, Bai X, Wang X, Tuoheti K, Cao Y, Zuo Y, Zhang X, Liu T. RRM2 is a putative biomarker and promotes bladder cancer progression via PI3K\/AKT\/mTOR pathway. J Cell Physiol. 2025;240(1):e31501. https:\/\/doi.org\/10.1002\/jcp.31501","journal-title":"J Cell Physiol"},{"issue":"5","key":"6847_CR83","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3892\/ijo.2019.4736","volume":"54","author":"Y Osako","year":"2019","unstructured":"Osako Y, Yoshino H, Sakaguchi T, Sugita S, Yonemori M, Nakagawa M, Enokida H. Potential tumor\u2013suppressive role of microRNA\u201399a\u20133p in sunitinib\u2013resistant renal cell carcinoma cells through the regulation of RRM2. Int J Oncol. 2019;54(5):1759\u201370. https:\/\/doi.org\/10.3892\/ijo.2019.4736","journal-title":"Int J Oncol"},{"issue":"21","key":"6847_CR84","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1158\/0008-5472.CAN-13-1094","volume":"73","author":"B Zhou","year":"2013","unstructured":"Zhou B, Su L, Hu S, Hu W, Yip MLR, Wu J, Gaur S, Smith DL, Yuan Y-C, Synold TW, et al. A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance. Cancer Res. 2013;73(21):6484\u201393. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1094","journal-title":"Cancer Res"},{"key":"6847_CR85","doi-asserted-by":"publisher","first-page":"103963","DOI":"10.1016\/j.ebiom.2022.103963","volume":"78","author":"X Li","year":"2022","unstructured":"Li X, Shong K, Kim W, Yuan M, Yang H, Sato Y, Kume H, Ogawa S, Turkez H, Shoaie S, et al. Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach. EBioMedicine. 2022;78:103963. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103963","journal-title":"EBioMedicine"},{"issue":"1","key":"6847_CR86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-021-01393-9","volume":"20","author":"S Ohmura","year":"2021","unstructured":"Ohmura S, Marchetto A, Orth MF, Li J, Jabar S, Ranft A, Vinca E, Ceranski K, Carre\u00f1o-Gonzalez MJ, Romero-P\u00e9rez L, et al. Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in ewing sarcoma. Mol Cancer. 2021;20(1):97. https:\/\/doi.org\/10.1186\/s12943-021-01393-9","journal-title":"Mol Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06847-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:16:25Z","timestamp":1757240185000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06847-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6847"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06847-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was performed in accordance with the 1975 Declaration of Helsinki and was approved by the Medical Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University (SZRJJ: NO. 2024\u2009\u2212\u2009253). All of the authors agree to the submission and consent for publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"795"}}